Phibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.73, $0.13 better than the analyst estimate of $0.60. Revenue for the quarter came in at $363.9 million versus the consensus estimate of $345.44 million.

GUIDANCE:

Phibro Animal Health sees FY2026 EPS of $2.64-$2.81, versus the consensus of $2.63. Phibro Animal Health sees FY2026 revenue of $1.43-1.48 billion, versus the consensus of $1.459 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.